Journal of The Korean Society of Inherited Metabolic disease (대한유전성대사질환학회지)

The Korea Society of Inherited Metabolic Disease (대한유전성대사질환학회)
권호 표지

Heterogenous Clinical Manifestations in Adult Patients with Late Diagnosis of Glycogen Storage Disease type Ia

성인기에 진단된 당원병 제 Ia형의 다양한 임상 양상

  • Kim, Yoo-Mi (Department of Pediatrics, College of Medicine, Pusan National University Children's Hospital) ;
  • Cheon, Chong Kun (Department of Pediatrics, College of Medicine, Pusan National University Children's Hospital) ;
  • Kim, Gu-Hwan (Medical Genetics Center, Asan Medical Center Children's Hospital University of Ulsan College of Medicine) ;
  • Yoo, Han-Wook (Medical Genetics Center, Asan Medical Center Children's Hospital University of Ulsan College of Medicine)
  • 김유미 (부산대학교 의과대학 소아과학교실) ;
  • 전종근 (부산대학교 의과대학 소아과학교실) ;
  • 김구환 (부산대학교 어린이병원 소아청소년과) ;
  • 유한욱 (부산대학교 어린이병원 소아청소년과)
  • Published : 2015.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Glycogen storage disease (GSD) type Ia is rare inborn metabolic disorder, caused by glucose-6-phosphatase deficiency. It characterized by hepatomegaly, hypoglycemia, lactic acidosis, hypertriglyceridemia, and hyperuricemia and it is usually manifested in the infantile period. In addition, it is also associated with growth failure, pubertal delay, anemia, platelet dysfunction, osteopenia, and pulmonary hypertension. Hepatocellular adenoma and renal dysfunction are frequent late complications. Delayed diagnosis and inappropriate therapy lead to many complications such as growth failure, osteoporosis, refractory gout, renal failure, hepatocellular carcinoma (HCC), and pulmonary hypertension. Here, two Korean sisters diagnosed with GSD Ia, aged 33 and 36 respectively, were described and compared to recent articles about four adults with late diagnosis of GSD Ia. One sister had typical manifestations of GSD Ia including short stature (height, 145 cm), multiple hepatic adenoma, chronic kidney disease stage IV, and severe osteoporosis, whereas the older sister had normal stature (162 cm), one tiny hepatic nodule, and normal renal function. Direct sequencing of G6PC in two sisters identified a homozygous splicing mutation, c.645G>T, which is a prevalent mutation in Korea. Interestingly, our cases and four adults from recent reports had asymptomatic mild hypoglycemia and various manifestations including renal failure, HCC, fatty liver, or uncontrolled hyperlipidemia. These adult cases represent not only heterogenous phenotype to genotype within family members with GSD Ia but also long-term complications such as gouty arthritis, renal failure, and osteoporosis in untreated adult GSD Ia patients. In addition, lactic academia and hypertriglyceridemia are good markers of GSD Ia to distinguish from metabolic disease.

당원병 Ia형은 glucose-6-phosphatase 효소의 결핍으로 인해 발생되는 상염색체열성 질환으로 특징적인 임상양상으로 대부분 영아기에 진단되나 증상의 경중에 따라 진단 연령이 늦어지기도 한다. 또한 환자 진단 시 유전 양식을 고려한 올바른 유전 상담과 더불어 형제, 자매에 대한 스크리닝이 중요하겠다. 본 연구는 성인기에 진단된 GSD Ia 자매에서의 임상양상의 차이를 기술하고 성인기 합병증에 대한 문헌을 고찰하여, 특히 간질환, 신부전 또는 대사성 질환으로 진료 받는 성인 환자들에서 당원병에 대한 감별과 당원병 진단 시 합병증에 대한 검사와 관리에 대해 필요성을 보고하는 바이다. 저혈당, 고지혈증, 고요산증, 젖산혈증, 대사성 산증, 기관 내 당원 축척에 대한 적절한 검사 및 약물 요법을 통해 급성 및 만성 합병증 예방과 적절한 치료를 위해 의료진의 체계적인 접근 및 노력이 필요하겠다.

Keywords

References

  1. Hicks J, Wartchow E, Mierau G. Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol 2011;35:183-96. https://doi.org/10.3109/01913123.2011.601404
  2. Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, et al. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis 2011;20:27.
  3. Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002;2:121-43. https://doi.org/10.2174/1566524024605798
  4. Moses SW. Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr 2002;161(Suppl 1):S2-9. https://doi.org/10.1007/BF02679988
  5. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that causeglycogenstoragediseasetypeIa. Science 1993;262:580-3. https://doi.org/10.1126/science.8211187
  6. Lei KJ, Chen H, Pan CJ, Ward JM, Mosinger B Jr, Lee EJ, et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-Ia mouse. Nat Genet 1996;13:203-9. https://doi.org/10.1038/ng0696-203
  7. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al. Glycogen storage disease in adults. Ann Intern Med 1994;120:218-26. https://doi.org/10.7326/0003-4819-120-3-199402010-00008
  8. Carvalho PM, Silva NJ, Dias PG, Porto JF, Santos LC, Costa JM. Glycogen Storage Disease type Ia - a secondary cause for hyperlipidemia: report of five cases. J Diabetes Metab Disord 2013;12:25. https://doi.org/10.1186/2251-6581-12-25
  9. Cassiman D, Libbrecht L, Verslype C, Meersseman W, Troisi R, Zucman-Rossi J, et al. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol 2010;53:213-7. https://doi.org/10.1016/j.jhep.2010.03.002
  10. Shieh JJ, Lu YH, Huang SW, Huang YH, Sun CH, Chiou HJ, et al. Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type Ia. Gene 2012;509:154-7. https://doi.org/10.1016/j.gene.2012.07.057
  11. Araoka T, Takeoka H, Abe H, Kishi S, Araki M, Nishioka K, et al. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia. Intern Med 2010;49:1787-92. https://doi.org/10.2169/internalmedicine.49.3425
  12. Choi J, Ko JM, Kim GH, Yoo HW. Clinical Manifestation and Effect of Corn Starch on Height Growth in Korean Patients with Glycogen Storage Disease Type Ia. J Korean Soc Pediatr Endocrinol 2007;12:35-40.
  13. Ki CS, Han SH, Kim HJ, Lee SG, Kim EJ, Kim JW, et al. Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia. ClinGenet 2004;65:487-9.
  14. Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002;2:121-43. https://doi.org/10.2174/1566524024605798
  15. Lei KJ, Chen YT, Chen H, Wong LJ, Liu JL, Mc Conkie-Rosell A, et al. Genetic basis of glycogen storage disease type Ia: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet 1995;57:766-71.
  16. Matern D, Seydewitz HH, Bali D, Lang C, Chen YT. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Eur J Pediatr 2002;161(Suppl 1):S10-9. https://doi.org/10.1007/BF02679989
  17. Nakamura T, Ozawa T, Kawasaki T, Nakamura H, Sugimura H. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type Ia with reference to hepatic tumors. J Gastroenterol Hepatol 2001;16:1402-8. https://doi.org/10.1046/j.1440-1746.2001.02645.x
  18. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP, at al. Guidelines for management of glycogen storage disease type I -European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161:S112-9. https://doi.org/10.1007/x00431-001-0876-6
  19. Shah KK, O'Dell SD. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type Ia: a systematic review and meta-analysis. J Hum Nutr Diet 2013;26:329-39. https://doi.org/10.1111/jhn.12030
  20. Martens DH, Rake JP, Navis G, Fidler V, van Dael CM, Smit GP. Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. Clin J Am Soc Nephrol 2009;4:1741-6. https://doi.org/10.2215/CJN.00050109
  21. Araoka T, Takeoka H, Abe H, Kishi S, Araki M, Nishioka K, et al. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia. Intern Med. 2010;49:1787-92. https://doi.org/10.2169/internalmedicine.49.3425
  22. Franco LM, Krishnamurthy V, Bali D, Weinstein DA, Arn P, Clary B,et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 2005;28:153-62. https://doi.org/10.1007/s10545-005-7500-2
  23. Sakamoto A, Hayashi H, Sakamoto I, Isomoto I, Eguchi S, Takatsuki M, et al. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdom Imaging 2012;37:239-43. https://doi.org/10.1007/s00261-011-9721-1
  24. Ueno M, Murakami T, Takeda A, Kubota M. Efficacy of oral sildenafil in a beraprost-treated patient with severe pulmonary hypertension secondary to type I glycogen storage disease. Circ J 2009;73:1965-8. https://doi.org/10.1253/circj.CJ-08-0181